Ivo Claassen is the head of Veterinary Medicines Division at the European Medicines Agency and has over 35 years of experience in multiple roles in development, production, quality and regulatory affairs of medicinal products.

Ivo gained his experience in the management of vaccine production, R&D, QA/QC and the regulatory assessment of veterinary medicinal products. He was a member of the EMA Committee for Veterinary Medicinal Products (CVMP) with specific focus on quality control of biotechnological products. Ivo is responsible for the implementation of the veterinary medicines regulation (EU) 2019/6 which contains multiple provisions to support innovation in veterinary medicines and on the reduction of risks related to AMR. This includes a major overhaul of the monitoring of sales and use data for veterinary antimicrobials, as well as limitations on the use of antimicrobials in veterinary practice.

Before Ivo joined the Agency he has worked internationally on capacity building for veterinary infectious disease management, including laboratory diagnosis, vaccine production and field trials.